MDVerse

Curated by Signal

AI-powered software for personalized precision therapies

Overview

AI-powered software for personalized precision therapies. The platform utilizes next-generation software, analytics, and generative AI to drive personalized and precision therapies. It has applications for cellular immunotherapy, gene editing, and stem cells.

Key facts

Founded: 2022
Headquarters: Fremont, United States
Stage: Sign up to view
Industry: Health Technology

Business model

7 products and services: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Health Technology companies

Pharmacy Marketplace
AI-based purchasing assistant tool for pharmacy owners
Health TechnologyBessemer, United States
Papyrus Medical
Provider of practice management platform for healthcare organisations
Health TechnologyWarwick, United States
Exero Vet
Provider of a video platform for veterinary education
Health TechnologyNew Orleans, United States

About MDVerse

What does MDVerse do?

AI-powered software for personalized precision therapies.

Where is MDVerse headquartered?

MDVerse is headquartered in Fremont, United States.

When was MDVerse founded?

MDVerse was founded in 2022.

Which sector is MDVerse in?

MDVerse operates in Health Technology.

Who are MDVerse's competitors?

Companies similar to MDVerse include Pharmacy Marketplace, Papyrus Medical, and Exero Vet.